The tweet was deleted by the author.
But we saved everything 🙂.
Caribou Biosciences announced its participation in the upcoming Jefferies Global Healthcare Conference in New York.
The company will join leading industry players to discuss innovation in cell therapy and CRISPR technologies. The event provides an opportunity for Caribou Biosciences to showcase its latest advancements and connect with investors and partners in the healthcare sector.
Caribou Biosciences has recently focused on engaging with the investment community at major industry gatherings. CEO Rachel Haurwitz was scheduled to speak at the BofA Securities Health Care Conference in Las Vegas to discuss developments in biotech. She also participated in a Bank of America Securities Health Care Conference fireside chat webcast.